CN117025627A - Tobacco chloride channel protein NtCLC13, and coding gene and application thereof - Google Patents
Tobacco chloride channel protein NtCLC13, and coding gene and application thereof Download PDFInfo
- Publication number
- CN117025627A CN117025627A CN202310785468.5A CN202310785468A CN117025627A CN 117025627 A CN117025627 A CN 117025627A CN 202310785468 A CN202310785468 A CN 202310785468A CN 117025627 A CN117025627 A CN 117025627A
- Authority
- CN
- China
- Prior art keywords
- tobacco
- ntclc13
- gene
- channel protein
- chloride channel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 129
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 111
- 101710128223 Chloride channel protein Proteins 0.000 title claims abstract description 36
- 244000061176 Nicotiana tabacum Species 0.000 title abstract description 12
- 241000208125 Nicotiana Species 0.000 claims abstract description 117
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 43
- 239000013598 vector Substances 0.000 claims abstract description 23
- 238000010362 genome editing Methods 0.000 claims abstract description 22
- 230000002829 reductive effect Effects 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 16
- 239000000460 chlorine Substances 0.000 claims abstract description 15
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 15
- 230000001105 regulatory effect Effects 0.000 claims abstract description 14
- 230000001276 controlling effect Effects 0.000 claims abstract description 13
- 239000002773 nucleotide Substances 0.000 claims description 16
- 125000003729 nucleotide group Chemical group 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 15
- 108020004414 DNA Proteins 0.000 claims description 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 10
- 230000006870 function Effects 0.000 claims description 10
- 238000012163 sequencing technique Methods 0.000 claims description 7
- 108091027544 Subgenomic mRNA Proteins 0.000 claims description 5
- 102000053602 DNA Human genes 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 125000000539 amino acid group Chemical group 0.000 claims description 3
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 abstract description 32
- 108091033409 CRISPR Proteins 0.000 abstract description 24
- 238000010354 CRISPR gene editing Methods 0.000 abstract description 12
- 238000005516 engineering process Methods 0.000 abstract description 11
- 238000010367 cloning Methods 0.000 abstract description 8
- 241000589158 Agrobacterium Species 0.000 abstract description 7
- 238000003209 gene knockout Methods 0.000 abstract description 5
- 230000004960 subcellular localization Effects 0.000 abstract description 5
- 238000004458 analytical method Methods 0.000 abstract description 4
- 210000000805 cytoplasm Anatomy 0.000 abstract description 4
- 230000033228 biological regulation Effects 0.000 abstract description 2
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 230000037427 ion transport Effects 0.000 abstract description 2
- 230000036961 partial effect Effects 0.000 abstract description 2
- 238000011426 transformation method Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000002609 medium Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 11
- 230000006872 improvement Effects 0.000 description 10
- 238000012408 PCR amplification Methods 0.000 description 9
- 238000012258 culturing Methods 0.000 description 9
- 239000007787 solid Substances 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 102000011045 Chloride Channels Human genes 0.000 description 5
- 108010062745 Chloride Channels Proteins 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 238000000137 annealing Methods 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 230000009261 transgenic effect Effects 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000219194 Arabidopsis Species 0.000 description 3
- 108091064523 Clc family Proteins 0.000 description 3
- 230000004544 DNA amplification Effects 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 238000010802 RNA extraction kit Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000003938 response to stress Effects 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- 102000034573 Channels Human genes 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000008635 plant growth Effects 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- -1 polysaccharide polyphenol Chemical class 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 210000002377 thylakoid Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000565357 Fraxinus nigra Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 241000207746 Nicotiana benthamiana Species 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001002356 Valeriana edulis Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 101150105830 clc gene Proteins 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Nutrition Science (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
The invention discloses tobacco chloride channel protein NtCLC13, and a coding gene and application thereof, and belongs to the technical field of plant genetic engineering. The coding gene NtCLC13 of the tobacco chloride channel protein NtCLC13 is obtained through cloning, and subcellular localization analysis is utilized to find that the tobacco chloride channel protein NtCLC13 is localized in cytoplasm. And transferring the constructed gene editing vector into a tobacco plant by using a CRISPR/Cas9 technology through an agrobacterium transformation method, and successfully constructing the NtCLC13 gene knockout tobacco plant. The chloridion content of the leaves of the knocked-out plant is obviously reduced, which makes it possible to cultivate new varieties of low-chlorine tobacco, and provides a new direction for improving the condition of higher chloridion content of flue-cured tobacco in partial tobacco areas in China. Meanwhile, the gene network for regulating and controlling chloride ions in tobacco is enriched, and the method has important significance for regulating and controlling the content of the chloride ions in the tobacco and further understanding the molecular regulation and control of chloride ion transport.
Description
Technical Field
The invention relates to tobacco chloride channel protein NtCLC13, and a coding gene and application thereof, and belongs to the technical field of plant genetic engineering.
Background
The existing researches generally show that the chloride ion content in the tobacco leaves is preferably 0.3-0.8, the smoldering fire-holding performance can be influenced when the content reaches 1%, and the black ash flameout phenomenon can occur when the content is higher than 1%; on the other hand, when the content of chloride ions in tobacco leaves is too high, the starch is accumulated more, the leaves are thick and brittle, and the moisture absorption is high, so that the color is easy to deepen during storage, and bad smell is generated. In summary, the chloride ion content in tobacco has a relatively important direct impact on the quality of tobacco. At present, the content of chloride ions in tobacco leaves in partial tobacco areas such as Henan and Yunnan is higher, the quality and the yield of the tobacco leaves are reduced, and the problems which need to be solved by growers and researchers are solved.
The traditional improvement method starts from a cultivation technology, and the quality of tobacco leaves is stabilized and improved by optimizing field management measures and perfecting a modulation fermentation technology. However, in general, these measures have not fundamentally changed the situation that the quality of the tobacco leaves is low and the industrial applicability is not strong.
With the rapid development of genomics, especially gene editing technology, the relationship between chloride ion accumulation in tobacco leaves and related genes is becoming more and more well known. Based on the prior studies it is already known that: for the Chloride Channel protein (CLC) family, 7 members of arabidopsis have been studied to show that AtCLCa plays a key role in driving nitrate into vacuoles, whereas AtCLCb does not; other AtCLCs are distributed in other cell intervals, and AtCLCd and AtCLCf can play an acidification role in transferring the Golgi vesicle network; atCLCe may be involved in the anion permeability of thylakoid membranes; atCLCg is consistent with AtCLCc in function and participates in plant salt stress. An Anne Marmagne et al, when studying Arabidopsis CLCf found (Two members of the Arabidopsis CLC (chloride channel) family, atCLCe and AtCLCf, are associated with thylakoid and Golgi membranes, resectively, journal of Experimental Botany,2007, 58 (12): 3385-3393), that AtCLCf was localized on the Golgi membrane and functionally complemented with a mutant of yeast gef1 disrupted in the single CLC gene encoding a Golgi-related protein. However, in general, CLC family proteins function are not completely identical in different species due to their diversity. For tobacco variety improvement only, the in-depth research on the function of CLC family proteins in tobacco can lay a theoretical basis and an application basis for tobacco variety improvement and even other plant improvement. Therefore, the CLC family protein members and related functions thereof in the tobacco are excavated, and the method has important significance for regulating and controlling the content of chloride ions in the tobacco and further understanding the molecular regulation and control of chloride ion transport.
Disclosure of Invention
To solve the above problems, a first object of the present invention is to provide a tobacco chloride channel protein coding gene NtCLC13, which can code for tobacco chloride channel protein NtCLC13, thereby regulating and controlling chloride transport in tobacco.
The invention provides a tobacco chloride channel protein NtCLC13, and experiments prove that the NtCLC13 protein participates in absorption and transportation of chloride ions in tobacco, and the content of the chloride ions in the tobacco can be regulated and controlled by regulating and controlling the expression of the protein.
The third purpose of the invention is to provide the application of the tobacco chloride channel protein coding gene NtCLC13 gene in regulating and controlling the transport of tobacco chloride ions, and experiments prove that regulating and controlling the expression of the NtCLC13 gene can influence the content of the chloride ions in the tobacco, and enrich a gene network for regulating and controlling the chloride ions in the tobacco.
The fourth object of the invention is to provide the application of the tobacco chloridion channel protein coding gene NtCLC13 gene in obtaining low-chlorine tobacco varieties, and the CRISPR/Cas9 gene editing technology is used for knocking out the NtCLC13 gene in tobacco plants, so that the chloridion content in leaves of the knocked-out plant is obviously reduced, and the low-chlorine tobacco varieties are obtained.
In order to achieve the above purpose, the tobacco chloride channel protein coding gene NtCLC13 adopts the following technical scheme:
a tobacco chloride channel protein coding gene NtCLC13 gene, characterized in that: the nucleotide sequence is as follows:
(1) A nucleotide sequence shown as SEQ ID NO. 1;
(2) The nucleotide sequence shown in SEQ ID NO.1 is substituted and/or deleted and/or added with one or more nucleotides and expresses the nucleotide sequence of the same functional protein.
The beneficial effects of the technical scheme are that: according to the invention, a specific primer is designed, and the coding gene NtCLC13 of the tobacco chloridion channel protein is obtained through cloning, and the transfer of chloridion to the overground part is reduced by inhibiting the expression of the coding gene NtCLC13 in tobacco, so that the process of regulating and controlling the chloridion transfer in tobacco is shown by the NtCLC13 gene.
In order to achieve the above purpose, the technical scheme adopted by the tobacco chloride channel protein NtCLC13 is as follows:
a tobacco chloride channel protein NtCLC13, having the amino acid sequence:
(1) An amino acid sequence shown in SEQ ID NO. 2;
(2) The amino acid sequence shown in SEQ ID NO.2 is a derivative protein with identical functions and with one or more amino acid residues replaced and/or deleted and/or added.
The beneficial effects of the technical scheme are that: the NtCLC13 protein is encoded and expressed by the NtCLC13 gene, and the experiments prove that the tobacco chloride ion channel protein NtCLC13 is closely related to absorption and transportation of chloride ions in tobacco, the expression of the tobacco chloride ion channel protein NtCLC13 is inhibited, the capacity of transporting the chloride ions from roots to overground parts is reduced, and the content of the chloride ions in tobacco leaves is obviously reduced.
In order to achieve the above purpose, the technical scheme adopted by the application of the tobacco chloride channel protein coding gene NtCLC13 gene in regulating and controlling tobacco chloride transport is as follows:
the application of the tobacco chloride channel protein coding gene NtCLC13 in regulating and controlling the transport of tobacco chloride ions.
The beneficial effects of the technical scheme are that: according to the tobacco plant with the NtCLC13 gene knocked-out obtained by the CRISPR/Cas9 technology, the difference between the NtCLC13 gene knocked-out plant in a normal culture medium and a control group is small, after salt stress is added, the growth of the NtCLC13 gene knocked-out plant is obviously inhibited compared with the control group, the root length is shortened, and the fact that the NtCLC13 gene participates in tobacco salt stress response is shown.
As a further improvement, the expression of the NtCLC13 gene was inhibited, and the content of chloride ions in tobacco leaves was significantly reduced.
The beneficial effects of the technical scheme are that: further detection shows that the content of chloride ions in the leaves of the NtCLC13 gene knockout strain is remarkably reduced, which indicates that the capacity of inhibiting the expression of the NtCLC13 gene and transporting chloride ions from roots to aerial parts is reduced.
In order to achieve the above purpose, the technical scheme adopted by the application of the tobacco chloride channel protein coding gene NtCLC13 gene in obtaining low-chlorine tobacco varieties is as follows:
the application of the tobacco chloride channel protein coding gene NtCLC13 gene in obtaining low-chlorine tobacco varieties is that the expression of the NtCLC13 gene is inhibited, so that chloride ions in tobacco leaves are reduced, and the low-chlorine tobacco varieties are obtained.
The beneficial effects of the technical scheme are that: according to the invention, the NtCLC13 gene is knocked out in tobacco through a CRISPR/Cas9 technology, the expression of the NtCLC13 gene is inhibited, a tobacco plant with the NtCLC13 gene knocked out is obtained, and the detection shows that the chloride ion content in the leaf of the obtained NtCLC13 gene knocked out plant is obviously reduced, so that a good foundation can be laid for cultivating new varieties of tobacco with low chloride content, and meanwhile, a technical support is provided for the stability of tobacco quality and the improvement of cigarette quality.
As a further improvement, the expression of the NtCLC13 gene is inhibited by constructing a gene editing vector and knocking out the NtCLC13 gene of the tobacco chloride channel protein coding gene.
The beneficial effects of the technical scheme are that: compared with traditional gene interference and the like, the CRISPR/Cas9 technology has the advantages of high knockout efficiency and simple and convenient operation.
As a further improvement, the gene editing vector is obtained by the following method: and (3) connecting the double-stranded DNA of the target site to a gene editing empty vector, and sequencing and identifying.
As a further improvement, the target site double-stranded DNA corresponds to the sgRNA sequence: TCTCGGCGATAGTGCTCCAC.
The beneficial effects of the technical scheme are that: the sgRNA can be used for effectively knocking out the NtCLC13 gene in tobacco, so that a tobacco plant with the NtCLC13 gene knocked out is successfully constructed, and a foundation is laid for researching the function of the NtCLC13 gene.
As a further improvement, the low-chlorine tobacco variety is obtained by the following method: and (3) transforming agrobacterium tumefaciens serving as an invader solution by using the gene editing vector, transforming tobacco, and screening and identifying to obtain a tobacco variety with obviously reduced leaf chloride ion content.
Drawings
FIG. 1 is a subcellular localization of tobacco NtCLC13 protein in example 3 according to the present invention;
FIG. 2 is a schematic representation of target site selection for NtCLC13 gene knockout in example 3 of the present invention;
FIG. 3 shows the NtCLC13 gene T in example 3 of the present invention 0 Sequencing result diagram of target site knocked out by the generation gene editing plant;
FIG. 4 shows the phenotype of the NtCLC13 gene-edited plant under salt stress in example 3 of the present invention;
fig. 5 is a graph of leaf chloride ion content of NtCLC13 gene-edited plants in example 3 of the present invention (representing p < 0.01).
Detailed Description
The present invention will be described in further detail with reference to specific examples. The equipment and reagents used in the examples, experimental examples and comparative examples were all commercially available, except for the specific descriptions.
Biological material:
tobacco variety: k326 and medium smoke 100, the seeds used were all supplied by the national tobacco gene research center.
And (3) a carrier: pCS1300 was given to wuhan-tian biotechnology limited; the CRISPR/Cas9 vector is provided by the national emphasis laboratory of silkworm genome biology at southwest university.
Strains: trans5 alpha chemically competent cells, purchased from Beijing full gold biotechnology Co., ltd; GV3101 Agrobacterium competent cells, purchased from Shanghai Biotechnology, inc.; primer synthesis and DNA sequencing were performed by Beijing Liuhua macrogene technologies Inc.
Experimental reagent: RNA extraction kit (RNAprep Pure polysaccharide polyphenol plant total RNA extraction kit), genome extraction kit (polysaccharide polyphenol plant genome DNA extraction kit) were purchased from the company of the root biochemistry science and technology (beijing); fluorescent quantification kit, reverse transcription kit (Transcriptor First Strand cDNA Synthesis Kit) were purchased from Roche, switzerland; DNA amplification enzymes purchased from beijing full gold biotechnology limited; restriction enzyme BsaI, plasmid extraction kit and DNA gel recovery kit were purchased from Takara Bio Inc.
Experimental facilities: PCR instrument Tprofessional Thermocycler, biomera company; quantitative PCR instrument LightCycler96, roche company.
Example 1 tobacco chloride channel protein encoding Gene NtCLC13 Gene
The nucleotide sequence of the tobacco chloride channel protein coding gene NtCLC13 gene in the embodiment is as follows:
(1) A nucleotide sequence shown as SEQ ID NO. 1;
(2) The nucleotide sequence shown in SEQ ID NO.1 is substituted and/or deleted and/or added with one or more nucleotides and expresses the nucleotide sequence of the same functional protein.
Example 2 tobacco chloride channel protein NtCLC13
The amino acid sequence of tobacco chloride channel protein NtCLC13 in this example is:
(1) An amino acid sequence shown in SEQ ID NO. 2;
(2) The amino acid sequence shown in SEQ ID NO.2 is a derivative protein with identical functions and with one or more amino acid residues replaced and/or deleted and/or added.
Example 3 application of tobacco chloride channel protein coding gene NtCLC13 gene in obtaining low-chlorine tobacco variety
In the embodiment, the NtCLC13 gene is successfully cloned through PCR, subcellular localization discovers that the tobacco NtCLC13 protein is localized in cytoplasm, and in order to further dig the functions of the tobacco, a gene editing vector of the NtCLC13 gene is constructed, the gene editing vector is transformed into a tobacco plant by using an agrobacterium transformation method, and the tobacco plant with the NtCLC13 gene knocked out is successfully constructed. Salt stress experiments show that the NtCLC13 gene participates in tobacco salt stress response and is used for knocking out the strain T 1 The generation is cultivated, and the detection shows that the chloride ion content in the leaves of the NtCLC13 gene knockout strain is obviously reduced. The specific implementation operation is as follows:
1. cloning and subcellular localization of chloride channel protein coding gene NtCLC13
1) Cloning of the NtCLC13 Gene
Cloning and obtaining procedures of the NtCLC13 gene are as follows:
(1) Extracting RNA and reverse transcribing cDNA
And (3) inoculating the K326 seeds to an MS culture medium for germination after disinfecting, transplanting seedlings into a pot after two weeks of germination, culturing in a plant culture room with a culture temperature of 23-26 ℃, transferring the seedlings to a 1/2MS liquid culture medium for continuous culture when the tobacco seedlings grow to six leaves and one heart, selecting roots for sampling after two weeks, quick-freezing with liquid nitrogen for later use, and extracting total RNA of tobacco roots by using a plant RNA extraction kit. During RNA extraction, the method is carried out by referring to the instruction of the kit, and then reverse transcription is carried out to obtain cDNA for standby.
(2) Designing primer for PCR amplification
The PCR amplification primer sequences were as follows:
NtCLC13-F:5'-ATGACGGGAGGCGAGTAC-3' (SEQ ID NO. 3);
NtCLC13-R:5'-CTACATTGAAAAGATGC-3' (SEQ ID NO. 4).
PCR amplification was performed using the cDNA reverse transcribed in step (1) as a template and the above primers.
The PCR amplification system is as follows: 5 XGCL buffer 10. Mu.L, cDNA 2. Mu.L, 1. Mu.L each of the upstream and downstream primers, dNTP 6. Mu.L, GXL DNA Polymerase. Mu.L, and sterilized water to 50. Mu.L.
The PCR amplification conditions were: 98 ℃ for 10sec;55 ℃, 15sec,68 ℃, 2min,30 cycles. The PCR products were subjected to agarose electrophoresis detection and analysis, and the PCR amplified products were purified and recovered by referring to the DNA gel recovery kit instructions.
The purified product was then ligated onto pFF19 vector as follows: DNA amplification product, 6. Mu.L; pFF19 vector, 1. Mu.L; after mixing, the mixture was connected at 25℃for 25min.
The ligation products were transformed into E.coli DH 5. Alpha. Competent cells as follows:
taking out competent cells from a refrigerator at-80 ℃, putting the competent cells on ice to dissolve the competent cells, adding a connection product into 100 mu L DH5 alpha competent cells, flicking and mixing the competent cells uniformly, and carrying out ice bath for 20min; heat shock in a water bath at 42 ℃ for 90s, and immediately placing on ice for 2min; 900. Mu.L of LB (without antibiotics) liquid medium equilibrated to room temperature was added, and cultured with shaking at 37℃for 1h; centrifugation at 4000rpm for 3min, removing part of the supernatant, leaving 100. Mu.L of the pellet, mixing well, spreading evenly on LB solid plates (containing 50. Mu.g/. Mu.L kanamycin), inverting the dishes, and culturing overnight at 37 ℃.
The next day, the monoclonal was picked and sequenced.
Sequencing results and analysis results show that the length of the coding region of the NtCLC13 gene is 2238bp nucleotides; after analysis of the gene, the amino acid sequence of the encoded NtCLC13 protein is shown as SEQ ID NO. 2.
2) Subcellular localization of tobacco NtCLC13 protein
Primers pCS1300S-NtCLC13F and pCS1300S-NtCLC13R were designed, and NtCLC13 was cloned into pCS1300S vector containing GFP tag, the primer sequences were:
pCS1300S-NtCLC13F:5’-GCTTTCGCGAGCTCGGTACCATGACGGGAGGCGAGTAC-3' (SEQ ID NO. 5);
pCS1300S-NtCLC13R:5’-CCCTTGCTCACCATGGATCCCATTGAAAAGATGC-3' (SEQ ID NO. 6).
Note that: the underlined part is the linker sequence.
PCR amplification System and reaction procedure the same as in the cloning of part 1) the NtCLC13 gene. The PCR product obtained was ligated to pCS1300 vector using In-Fusion enzyme In the following manner: 2. Mu.L of DNA amplification product; 2. Mu.L of pCS1300S vector; in-Fusion enzyme 1. Mu.L. After mixing, the mixture was connected at 50℃for 15min. The ligation product was transformed into E.coli DH 5. Alpha. Competence and single colony was picked for sequencing.
The plasmid with correct sequence was extracted from high quality plasmid by plasmid big extraction kit, transformed into Nicotiana benthamiana protoplast, and compared with mitochondrial marker (red), and the result is shown in FIG. 1, wherein NtCLC13 is localized in cytoplasm.
2. Construction of Gene editing vector
In order to further understand the function of the NtCLC13 gene in the absorption and transportation of tobacco chloride ions, a CRISPR/Cas9 expression vector for knocking out the NtCLC13 gene is constructed, and the experimental process is as follows:
firstly, designing a target site according to the recognition characteristic of a CRISPR/Cas9 system, and designing a 20bp sgRNA target sequence in the 1 st exon region of the NtCLC13 gene, wherein the sgRNA sequence is as shown in figure 2: TCTCGGCGATAGTGCTCCAC (SEQ ID NO. 7) the knockout primer sequences NtCLC13-T1_F and NtCLC13-T1_R were designed as follows:
NtCLC13-T1_F: GTGGAGCACTATCGCCGAGAtgcaccagccgggaat (SEQ ID NO. 8);
NtCLC13-T1_R: ttctagctctaaaacGTGGAGCACTATCGCCGAGA (SEQ ID NO. 9).
The reaction system was designed to obtain a DNA double strand (annealing) of the target site, and 20. Mu.L of the reaction system was designed as follows: annealing Buffer for DNA OLigos (5×), 4 μl; upstream and downstream primers (NtCLC 13-T1_ F, ntCLC 13-T1_R), 4. Mu.L each (50. Mu. MoL/. Mu.L); nuclease-free water was supplemented to 20. Mu.L.
The reaction procedure is: 5min at 95 ℃, 0.1 ℃ every 8s, and 25 ℃; the reaction product is stored at 4 ℃ for standby or directly subjected to subsequent reaction.
Connecting the annealing product with a BsaI digested CRISPR/Cas9 vector, and screening to obtain a CRISPR/Cas9 expression vector for knocking out the NtCLC13 gene, wherein a 20 mu L connecting system is designed as follows: annealing product, 6 μl; 3 mu L of enzyme digestion product (BsaI enzyme digested CRISPR/Cas9 vector); 10×T DNA Ligase Buffer, 2. Mu.L; t4 DNA Ligase, 1. Mu.L; sterilized water was added to 20. Mu.L and connected at 37℃for 3 hours.
The connection product is transformed into competent cells of the escherichia coli, positive cloning is selected, amplification culture is carried out, plasmids are extracted, and after the construction success of the vectors is confirmed by PCR, the vectors are preserved at low temperature and used for agrobacterium transformation.
3. Obtaining transgenic plants
The CRISPR/Cas9 expression vector constructed in the steps is transformed into agrobacterium, and then tobacco plants are transformed, and transgenic plants with NtCLC13 gene knocked out are constructed, wherein the experimental process is as follows:
(1) Transformation of Agrobacterium
Taking out competent cells of Agrobacterium GV3101 from a refrigerator at-80 ℃, freezing and thawing on ice, adding 5 mu L of constructed gene editing vector when thawing is about to occur, flicking and mixing uniformly; ice-bath for 30min, freezing in liquid nitrogen for 5min, and immediately placing on ice after water bath at 37 ℃ for 5 min; adding 900 mu L of LB liquid medium without antibiotics, and culturing for 4h at 200rpm with shaking; centrifuging the bacterial liquid at 4500rpm for 3min, discarding half of the volume of supernatant, re-suspending, uniformly coating on LB solid medium containing Rif (100 mug/mL) and Kan (50 mug/mL), and inversely culturing at 28 ℃ for about 2-3 d until single colony is formed; and (3) selecting single bacterial colony, carrying out PCR identification on bacterial liquid after amplification and culture, and identifying the correct positive clone bacterial strain, namely the engineering bacteria with correct transformation.
(2) Transformation of tobacco plants
Taking aseptic seedling leaves of tobacco (medium tobacco 100) growing for about one month, processing the leaves into leaf discs with the diameter of 0.5cm by using a puncher, and pre-culturing the leaf discs after processing on an MS solid culture medium for 3d; culturing the transformed agrobacteria engineering bacteria to OD 600 About=0.6, centrifuging at 4000rpm for 5min to collect the thalli, and suspending the thalli with 20mL of MS liquid medium; then placing the pre-cultured leaf discs in bacterial liquid, and infecting for 10min; excess bacterial liquid around the leaf disc after dip-dyeing was blotted with sterile filter paper and darkened on solid medium of MS+6-BA (2 mg/L) +NAA (0.5 mg/L)Culturing for 3d; washing the leaf disc with sterile water containing Cef (400 mg/L), sucking off the excess liquid with sterile filter paper, transferring the leaf disc to MS solid screening medium containing 6-BA (2 mg/L), NAA (0.5 mg/L), cef (200 mg/L) and Kan (50 mg/L), and culturing at 28deg.C under light; when the adventitious bud length reached 0.5cm, the shoots were transferred to MS solid medium containing Cef (200 mg/L) and Kan (50 mg/L) for rooting.
(3) Identification of Gene editing
And after the plant is grown for about one month, a small number of leaves are taken, DNA is extracted by referring to a plant genome extraction kit instruction, and positive transgenic strains and mutant forms are detected by PCR amplification, cloning and sequencing methods. The specific identification method comprises the following steps:
on the NtCLC13 genome, a pair of detection primers is designed, which are located on both sides of the knockout target site, specifically:
NtCLC13-J-F:5'-GGAGTGAGTACGGTGTGCCAGAAGGCGATTTAGAAAGC-3' (SEQ ID NO. 10);
NtCLC13-J-R:5'-GAGTTGGATGCTGGATGGGCTGAAACTAACCCCGC-3' (SEQ ID NO. 11).
By T 0 And carrying out PCR amplification on the transgenic strain DNA template.
The PCR reaction system is as follows: 10 Xbuffer 2. Mu.L, cDNA 1. Mu.L, upstream and downstream primers 0.5. Mu.L each, dNTP 3. Mu.L, eazyTaq enzyme 1. Mu.L, and sterilized water to 20. Mu.L.
The PCR amplification conditions were: pre-denaturation at 94℃for 4min; denaturation at 94℃for 30s, annealing at 56℃for 30s, extension at 72℃for 40s for 25 cycles; and finally extending at 72 ℃ for 10min. The PCR product was Hi-tom sequenced.
Analytical sequencing results As shown in FIG. 3, at T 0 In the generation plants, the NtCLC13 gene was detected to have a deletion mutation of a single base at the target site of knockout, whereas the wild-type plants did not detect any mutation in the NtCLC13 gene, which indicates that the gene was deleted at T 0 The knockout of the NtCLC13 gene has been successfully realized in the generation of plants, and the edited plant is named NtCLC13 - 。
4. Phenotype observation of NtCLC13 gene editing plants
(1) Seed disinfection
Will smoke 100 (comparison to normalTobacco plants) and ntclc13 - Sterilizing the seeds of the editing material with 75% alcohol for 1-2min, sterilizing with 10% NaClO for 10min, and repeatedly washing with sterilized water for 3-5 times.
(2) Salt stress phenotype observations
The sterilized seeds were sown on 1/2MS solid medium with 200mM NaCl and 1/2MS solid medium without salt was used as a control, and the phenotype of the plants on the plates was observed after 2-3 weeks.
The results are shown in FIG. 4, where ntclc13 was present in the normal medium - Plant growth was not significantly different from control, and ntclc13 after salt stress addition - Plant growth is obviously inhibited compared with a control, and root length is shortened, which indicates that the NtCLC13 gene participates in tobacco salt stress response.
5. Detection of chloride ion content of leaves of NtCLC13 gene editing plant
(1) Hydroponic test
NtCLC13 Gene editing plant T 1 The tobacco 100 plants in the generation and the control are planted in a plant culture room of a national tobacco gene research center, and the culture conditions are as follows: the temperature (23+/-1) DEG C, the relative humidity (60% +/-2%), the light culture for 16 hours and the dark culture for 8 hours. And (3) after the tobacco seedlings grow to a six-leaf stage, transferring the tobacco seedlings to Hoagland's nutrient solution for continuous culture, replacing the nutrient solution once after 1 week, culturing for 3 days, and taking the leaves for subsequent determination of chloride ion content. The leaves are quickly frozen by liquid nitrogen and then stored in a refrigerator at-80 ℃. Each strain is provided with 3 independent repeats, and at least 3 tobacco seedlings with consistent growth vigor are selected from each repeat.
(2) Determination of chloride ion content
After freeze-drying the stored leaf samples, grinding the leaf samples to powder by using a mixed vibration grinder, weighing about 0.0500g (accurate to 0.1 mg) of powder, placing the powder in 10mL of 5% (volume fraction) acetic acid, performing vibration extraction at 30 ℃ for 30min, filtering the powder by using qualitative filter paper, diluting the filtrate, and measuring the chloride ion content by using an Alalis MP6500 type desk pH meter in America An Laili.
As a result, as shown in fig. 5, after NtCLC13 gene editing, the chloride ion content in leaf was significantly reduced (representing p < 0.01).
In conclusion, the invention is realized by the method for preparing the tobacco NtCLC13 study of the gene, found that the NtCLC13 protein is localized on the cytoplasm; obtaining NtCLC13 gene knockout strain by gene editing technology, and after salt stress, ntCLC13 - The growth of the edited plant is inhibited, and the root length is obviously shortened compared with the control; the chloride ion content in the leaf of the edited plant is obviously reduced, and the tobacco plant with reduced chloride ion content of tobacco leaves is obtained.
The last explanation is: the above embodiments are only for illustrating the technical solution of the present invention, and not for limiting the same; although the invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical scheme described in the foregoing embodiments can be modified or some or all of the technical features thereof can be replaced by equivalents; such modifications and substitutions do not depart from the spirit of the invention.
Claims (9)
1. A tobacco chloride channel protein coding gene NtCLC13 gene, characterized in that: the nucleotide sequence is as follows:
(1) A nucleotide sequence shown as SEQ ID NO. 1;
(2) The nucleotide sequence shown in SEQ ID NO.1 is substituted and/or deleted and/or added with one or more nucleotides and expresses the nucleotide sequence of the same functional protein.
2. A tobacco chloride channel protein NtCLC13, characterized in that: the amino acid sequence is as follows:
(1) An amino acid sequence shown in SEQ ID NO. 2;
(2) The amino acid sequence shown in SEQ ID NO.2 is a derivative protein with identical functions and with one or more amino acid residues replaced and/or deleted and/or added.
3. Use of the tobacco chloride channel protein coding gene NtCLC13 gene of claim 1 for regulating and controlling tobacco chloride transport.
4. The use of the tobacco chloride channel protein coding gene NtCLC13 gene according to claim 3 for regulating and controlling tobacco chloride transport, characterized in that: inhibiting the expression of the NtCLC13 gene, and remarkably reducing the content of chloride ions in tobacco leaves.
5. Use of the tobacco chloride channel protein coding gene NtCLC13 gene according to claim 1 for obtaining low-chlorine tobacco varieties, characterized in that: the low-chlorine tobacco variety is obtained by inhibiting the expression of the NtCLC13 gene and reducing chloride ions in tobacco leaves.
6. The use of the tobacco chloride channel protein coding gene NtCLC13 gene according to claim 5 for obtaining low-chlorine tobacco varieties, characterized in that: the expression of the NtCLC13 gene is inhibited by constructing a gene editing vector and knocking out the tobacco chloride channel protein coding gene NtCLC13 gene.
7. The use of the tobacco chloride channel protein coding gene NtCLC13 gene according to claim 6 for obtaining low-chlorine tobacco varieties, characterized in that: the gene editing vector is obtained by the following method: and (3) connecting the double-stranded DNA of the target site to a gene editing empty vector, and sequencing and identifying.
8. The use of the tobacco chloride channel protein coding gene NtCLC13 gene according to claim 7 for obtaining low-chlorine tobacco varieties, characterized in that: the sgRNA sequence corresponding to the double-stranded DNA of the target site is as follows: TCTCGGCGATAGTGCTCCAC.
9. The use of the tobacco chloride channel protein coding gene NtCLC13 gene according to any one of claims 5-8 for obtaining low-chlorine tobacco varieties, characterized in that: the low-chlorine tobacco variety is obtained by the following method: and (3) transforming agrobacterium tumefaciens serving as an invader solution by using the gene editing vector, transforming tobacco, and screening and identifying to obtain a tobacco variety with obviously reduced leaf chloride ion content.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310785468.5A CN117025627A (en) | 2023-06-29 | 2023-06-29 | Tobacco chloride channel protein NtCLC13, and coding gene and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310785468.5A CN117025627A (en) | 2023-06-29 | 2023-06-29 | Tobacco chloride channel protein NtCLC13, and coding gene and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117025627A true CN117025627A (en) | 2023-11-10 |
Family
ID=88601162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310785468.5A Pending CN117025627A (en) | 2023-06-29 | 2023-06-29 | Tobacco chloride channel protein NtCLC13, and coding gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117025627A (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5854411A (en) * | 1997-01-09 | 1998-12-29 | Incyte Pharmaceuticals, Inc. | Human chloride channel |
US20060075522A1 (en) * | 2004-07-31 | 2006-04-06 | Jaclyn Cleveland | Genes and uses for plant improvement |
WO2007035650A2 (en) * | 2005-09-16 | 2007-03-29 | Monsanto Technology Llc | Methods for genetic control of insect infestations in plants and compositions thereof |
CN101054586A (en) * | 2007-03-29 | 2007-10-17 | 上海大学 | Rice chlorine ion passage gene OsCLC, coding protein and clone method thereof |
WO2014096283A2 (en) * | 2012-12-21 | 2014-06-26 | Philip Morris Products S.A | Tobacco specific nitrosamine reduction in plants |
CN108841834A (en) * | 2018-06-27 | 2018-11-20 | 中国烟草总公司郑州烟草研究院 | One tobacco chloride channel protein NtCLC2 and its application |
CN112760329A (en) * | 2021-03-11 | 2021-05-07 | 河南中烟工业有限责任公司 | Tobacco chloride channel protein gene NtCLC-F and application thereof |
WO2023036691A1 (en) * | 2021-09-10 | 2023-03-16 | Philip Morris Products S.A. | Modulating alkaloid profiles in nicotiana tabacum |
WO2023117701A1 (en) * | 2021-12-21 | 2023-06-29 | Philip Morris Products S.A. | Modulation of nicotine production by alteration of nicotinamidase expression or function in plants |
-
2023
- 2023-06-29 CN CN202310785468.5A patent/CN117025627A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5854411A (en) * | 1997-01-09 | 1998-12-29 | Incyte Pharmaceuticals, Inc. | Human chloride channel |
US20060075522A1 (en) * | 2004-07-31 | 2006-04-06 | Jaclyn Cleveland | Genes and uses for plant improvement |
WO2007035650A2 (en) * | 2005-09-16 | 2007-03-29 | Monsanto Technology Llc | Methods for genetic control of insect infestations in plants and compositions thereof |
CN101054586A (en) * | 2007-03-29 | 2007-10-17 | 上海大学 | Rice chlorine ion passage gene OsCLC, coding protein and clone method thereof |
WO2014096283A2 (en) * | 2012-12-21 | 2014-06-26 | Philip Morris Products S.A | Tobacco specific nitrosamine reduction in plants |
CN108841834A (en) * | 2018-06-27 | 2018-11-20 | 中国烟草总公司郑州烟草研究院 | One tobacco chloride channel protein NtCLC2 and its application |
CN112760329A (en) * | 2021-03-11 | 2021-05-07 | 河南中烟工业有限责任公司 | Tobacco chloride channel protein gene NtCLC-F and application thereof |
WO2023036691A1 (en) * | 2021-09-10 | 2023-03-16 | Philip Morris Products S.A. | Modulating alkaloid profiles in nicotiana tabacum |
WO2023117701A1 (en) * | 2021-12-21 | 2023-06-29 | Philip Morris Products S.A. | Modulation of nicotine production by alteration of nicotinamidase expression or function in plants |
Non-Patent Citations (5)
Title |
---|
HUI ZHANG等: "Identification and analysis of the chloride channel gene family members in tobacco (Nicotiana tabacum)", GENE, vol. 676, 26 June 2018 (2018-06-26), pages 56 - 64 * |
NCBI: "PREDICTED: Nicotiana tabacum chloride channel protein CLC-f-like (LOC1 07798879), transcript variant X2, mRNA", GENBANK DATABASE, 3 May 2016 (2016-05-03), pages 01 * |
康敏华;陈暖;杜喜玲;刘特;刘志学;: "水稻氯离子通道蛋白基因的克隆及表达分析", 西北植物学报, no. 04, 15 April 2011 (2011-04-15), pages 647 - 650 * |
张慧;金立锋;徐国云;翟妞;刘萍萍;陈千思;郑庆霞;陈霞;周会娜;: "烟草慢阴离子通道蛋白基因NtSLAH1的克隆及表达分析", 烟草科技, no. 03, 30 March 2018 (2018-03-30), pages 1 - 6 * |
王亚宁;张翔;范艺宽;李亮;毛家伟;司贤宗;: "烟草氯素营养研究进展与展望", 中国农学通报, no. 27, 25 September 2017 (2017-09-25), pages 66 - 70 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108949774B (en) | Method for obtaining multi-leaf alfalfa material by using MsPALM1 artificial site-specific mutant | |
CN110760515A (en) | lncRNA lnc12 and application thereof in regulation and control of adventitious root development of poplar | |
CN113528537A (en) | NtQPT2 gene mutant for reducing nicotine content in tobacco leaves and application thereof | |
Kang et al. | A robust genome-editing method for wild plant species Nicotiana attenuata | |
CN117025626A (en) | Tobacco nitrate transporter NtNPF7.4, encoding gene thereof, gene editing vector and application | |
CN115896128B (en) | Tobacco nitrate transporter NtNPF6.13, coding gene and application thereof | |
CN116574728A (en) | Potato tissue-specific enhancer and application thereof | |
CN113461794B (en) | Kit and method for regulating seed germination and application thereof | |
CN113416735B (en) | Tobacco germ cell specific high expression gene and application thereof | |
CN116590301A (en) | Hybridized tulip tree LhWUS gene and expression protein and application thereof | |
CN114854766A (en) | NtAIDP1 gene mutant for reducing nicotine content in tobacco leaves and application thereof | |
CN110106171A (en) | Long-chain non-coding RNA and its application in regulation plant frigostabile | |
CN117025627A (en) | Tobacco chloride channel protein NtCLC13, and coding gene and application thereof | |
CN112501185A (en) | Application of pineapple transcription factor AcWRKY28 in salt resistance of plants | |
CN118406698B (en) | Application of ZmWIND gene in improving corn genetic transformation efficiency | |
CN117210490B (en) | PCHR gene for regulating and controlling malus plant self-flower fructification and application thereof | |
CN114214325B (en) | Betula alnoides miR156a precursor gene and application thereof in promotion of plant branching formation | |
CN114805513B (en) | Tobacco NtOEE1 gene and application thereof in regulation of stem and leaf included angle and plant height | |
CN114891802B (en) | Application of OsDUF6 gene and encoding protein thereof in rice salt tolerance breeding | |
CN110106172A (en) | A kind of long-chain non-coding RNA and its application in regulation plant frigostabile | |
CN113862282B (en) | Soybean PCL homologous gene editing site and application thereof | |
CN110699362B (en) | AFP5 gene and application thereof | |
CN117051006A (en) | Gene for positively regulating flowering of bolting of Chinese cabbage and application thereof | |
CN117384919A (en) | NtERF283 gene, protein coded by same and application thereof | |
CN116590331A (en) | Application of SmD3-b in regulating drought and salt stress resistance of plants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |